Patents by Inventor Stefan Weitzer

Stefan Weitzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a HSPC117 molecule as RNA ligase
    Patent number: 9340779
    Abstract: The present invention relates to the use of HSPC117 molecules as RNA ligase, methods of ligating RNA molecules, kits for these methods and uses and transgenic cells.
    Type: Grant
    Filed: August 30, 2011
    Date of Patent: May 17, 2016
    Assignee: IMBA—INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH
    Inventors: Johannes Popow, Stefan Weitzer, Javier Martinez, Karl Mechtler, Alexander Schleiffer
  • USE OF A HSPC117 MOLECULE AS RNA LIGASE
    Publication number: 20130156748
    Abstract: The present invention relates to the use of HSPC117 molecules as RNA ligase, methods of ligating RNA molecules, kits for these methods and uses and transgenic cells.
    Type: Application
    Filed: August 30, 2011
    Publication date: June 20, 2013
    Applicant: IMBA-Institut fur Molekulare Biotechnologie GmbH
    Inventors: Johannes Popow, Stefan Weitzer, Javier Martinez, Karl Mechtler, Alexander Schleiffer
  • siRNA Kinase and Methods of Use
    Publication number: 20100154072
    Abstract: The invention is based on the finding that Clp1 has the activity of an RNA kinase. Clp1 is therefore useful as an enhancer of siRNA activity. It can be used per se, in kits or expressed in cell lines. Clp1 transgenic and Clp1 knock-out non-human animals are useful for studying the function of siRNAs. Clp1 is also useful in gene therapy to enhance the efficacy of therapeutic siRNAs.
    Type: Application
    Filed: May 29, 2007
    Publication date: June 17, 2010
    Inventors: Javier Martinez, Stefan Weitzer